2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
125
Myelodysplastic Syndromes
120
Precursor Cell Lymphoblastic Leukemia-Lymphoma
107
Leukemia
86
Hodgkin Disease
81
Leukemia, Lymphocytic, Chronic, B-Cell
78
Lymphoma
76
Multiple Myeloma
75
Lymphoma, Non-Hodgkin
75
Myeloproliferative Disorders
57
Graft vs Host Disease
55
Lymphoma, Follicular
54
Lymphoma, Mantle-Cell
50
Lymphoma, Large B-Cell, Diffuse
50
Leukemia, Myeloid, Accelerated Phase
50
Leukemia, Myelomonocytic, Chronic
48
Congenital Abnormalities
48
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
47
Hematologic Neoplasms
45
Lymphoma, B-Cell, Marginal Zone
44
Leukemia, Myeloid, Chronic-Phase
44
Burkitt Lymphoma
42
Primary Myelofibrosis
41
Blast Crisis
39
Neoplasms, Plasma Cell
38
Lymphoma, Large-Cell, Immunoblastic
34
Waldenstrom Macroglobulinemia
26
Myelodysplastic-Myeloproliferative Diseases
25
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
25
Anemia, Refractory, with Excess of Blasts
24
Interventions
apixaban
22
Rivaroxaban
16
Dalteparin
16
Enoxaparin
11
Heparin, Low-Molecular-Weight
10
Tinzaparin
8
Aspirin
8
Fondaparinux
4
Dabigatran
4
edoxaban
3
Warfarin
3
Nadroparin
3
bemiparin
2
abelacimab
2
Rosuvastatin Calcium
2
Observation
2
MAA868
2
sotorasib
1
ribociclib
1
reviparin
1
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
certoparin
1
calcium heparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
abemaciclib
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Tacrolimus
×
Clear all
NCT03083782
2017-10-11
ACT
Thomas Jefferson University
Phase 1
Completed
12 enrolled